Patient self-appraisal of change and minimal clinically important difference on the European organization for the research and treatment of cancer quality of life questionnaire core 30 before and during cancer therapy

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Hong, Fanxing ^a   Bosco, Jaclyn L F ^b   Bush, Nigel ^c   Berry, Donna L ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Joint Base Lewis McChord   (United States)

Author keywords

Cancer treatment; Health related quality of life; Minimal clinically important differences; Quality of life questionnaire core; Subject significance questionnaire

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; COGNITION; CONTROLLED STUDY; EFFECT SIZE; EMOTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SELF EVALUATION; SELF REPORT; SOCIAL STATUS; STEM CELL TRANSPLANTATION; SUBJECT SIGNIFICANCE QUESTIONNAIRE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COGNITION; DIAGNOSTIC SELF EVALUATION; EMOTIONS; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; SOCIAL PARTICIPATION; STATISTICS, NONPARAMETRIC; STEM CELL TRANSPLANTATION; UNITED STATES; YOUNG ADULT;

EID: 84875291109     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-165     Document Type: Article

References (23)

1. Osthus AA, Aarstad AK, Olofsson J, et al. Health-related quality of life scores in long-term head and neck cancer survivors predict subsequent survival: a prospective cohort study. Clin Otolaryngol 2011, 36:361-8. 10.1111/j.1749-4486.2011.02342.x, 21624101.
2. Svensson H, Hatschek T, Johansson H, et al. Health-related quality of life as prognostic factor for response, progression-free survival, and survival in women with metastatic breast cancer 2011, Med Oncol.
3. Wan Leung S, Lee TF, Chien CY, et al. Health-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires. BMC Cancer 2011, 11:128. 10.1186/1471-2407-11-128, 3083374, 21486431.
4. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85:365-76. 10.1093/jnci/85.5.365, 8433390.
5. Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998, 16:139-44.
6. King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 1996, 5:555-67. 10.1007/BF00439229, 8993101.
7. Grulke N, Albani C, Bailer H. Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire QLQ-C30. Bone Marrow Transplant 2012, 47:473-82. 10.1038/bmt.2011.107, 21602898.
8. Cocks K, King MT, Velikova G, et al. Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol 2011, 29:89-96. 10.1200/JCO.2010.28.0107, 21098316.
9. Ringash J, O'Sullivan B, Bezjak A, et al. Interpreting clinically significant changes in patient-reported outcomes. Cancer 2007, 110:196-202. 10.1002/cncr.22799, 17546575.
10. Cella D, Hahn EA, Dineen K. Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening. Qual Life Res 2002, 11:207-21. 10.1023/A:1015276414526, 12074259.
11. Maringwa J, Quinten C, King M, et al. Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. Ann Oncol 2011, 22:2107-12. 10.1093/annonc/mdq726, 21324954.
12. Kvam AK, Fayers PM, Wisloff F. Responsiveness and minimal important score differences in quality-of-life questionnaires: a comparison of the EORTC QLQ-C30 cancer-specific questionnaire to the generic utility questionnaires EQ-5D and 15D in patients with multiple myeloma. Eur J Haematol 2011, 87:330-7. 10.1111/j.1600-0609.2011.01665.x, 21668504.
13. Cocks K, King MT, Velikova G, et al. Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Eur J Cancer 2012, 48(11):1713-1721. 10.1016/j.ejca.2012.02.059, 22418017.
14. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989, 10:407-15. 10.1016/0197-2456(89)90005-6, 2691207.
15. Osoba D. Interpreting the meaningfulness of changes in health-related quality of life scores: lessons from studies in adults. Int J Cancer Suppl 1999, 12:132-7.
16. Berry DL, Blumenstein BA, Halpenny B, et al. Enhancing patient-provider communication with the electronic self-report assessment for cancer: a randomized trial. J Clin Oncol 2011, 29:1029-35. 10.1200/JCO.2010.30.3909, 3068053, 21282548.
17. Fayers P, Aaronson N, Bjordal K, et al. EORTC QLQ-C30 Scoring Manual (ed 3rd) 2001, EORTC: Brussels.
18. Rodrigues G, Bezjak A, Osoba D, et al. The relationship of changes in EORTC QLQ-C30 scores to ratings on the Subjective Significance Questionnaire in men with localized prostate cancer. Qual Life Res 2004, 13:1235-46.
19. Cohen J. Statistical power analysis for the behavioral sciences 1988, Hillsdale: Erlbaum.
20. Frodin U, Borjeson S, Lyth J, et al. A prospective evaluation of patients' health-related quality of life during auto-SCT: a 3-year follow-up. Bone Marrow Transplant 2011, 46:1345-52. 10.1038/bmt.2010.304, 21113189.
21. Schwartz CE, Sprangers MA. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med 1999, 48:1531-48. 10.1016/S0277-9536(99)00047-7, 10400255.
22. Tierney DK, Facione N, Padilla G, et al. Response shift: a theoretical exploration of quality of life following hematopoietic cell transplantation. Cancer Nurs 2007, 30:125-38. 10.1097/01.NCC.0000265002.79687.af, 17413778.
23. Kamper SJ, Maher CG, Mackay G. Global rating of change scales: a review of strengths and weaknesses and considerations for design. The Journal of manual & manipulative therapy 2009, 17(3):163-170.